Schonfeld Strategic Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,161
Closed -$68.2K 2310
2023
Q4
$68.2K Sell
1,161
-29,539
-96% -$1.74M ﹤0.01% 1561
2023
Q3
$1.34M Sell
30,700
-98,936
-76% -$4.31M 0.01% 810
2023
Q2
$4.68M Buy
129,636
+106,837
+469% +$3.86M 0.04% 505
2023
Q1
$848K Buy
22,799
+14,599
+178% +$543K 0.01% 1000
2022
Q4
$372K Sell
8,200
-15,227
-65% -$690K ﹤0.01% 1671
2022
Q3
$1.64M Sell
23,427
-8,574
-27% -$599K 0.01% 964
2022
Q2
$2.15M Buy
+32,001
New +$2.15M 0.02% 672
2022
Q1
Sell
-16,350
Closed -$2.4M 2848
2021
Q4
$2.4M Sell
16,350
-2,377
-13% -$349K 0.02% 604
2021
Q3
$3.31M Sell
18,727
-11,395
-38% -$2.02M 0.03% 500
2021
Q2
$4.87M Buy
+30,122
New +$4.87M 0.05% 448
2021
Q1
Sell
-1,692
Closed -$373K 2139
2020
Q4
$373K Sell
1,692
-94
-5% -$20.7K 0.01% 1093
2020
Q3
$297K Sell
1,786
-3,793
-68% -$631K 0.01% 1058
2020
Q2
$637K Sell
5,579
-11,076
-67% -$1.26M 0.02% 685
2020
Q1
$1.28M Sell
16,655
-11,482
-41% -$882K 0.08% 296
2019
Q4
$3.63M Sell
28,137
-96,863
-77% -$12.5M 0.09% 250
2019
Q3
$9.74M Sell
125,000
-95,400
-43% -$7.43M 0.29% 101
2019
Q2
$22.7M Buy
220,400
+59,200
+37% +$6.1M 0.8% 16
2019
Q1
$11.8M Buy
161,200
+70,300
+77% +$5.15M 0.41% 54
2018
Q4
$3.86M Buy
90,900
+36,400
+67% +$1.54M 0.15% 192
2018
Q3
$2.57M Sell
54,500
-34,600
-39% -$1.63M 0.11% 241
2018
Q2
$4.39M Buy
+89,100
New +$4.39M 0.24% 147
2018
Q1
Sell
-32,113
Closed -$586K 996
2017
Q4
$586K Buy
+32,113
New +$586K 0.05% 427